Interleukin-37 suppresses the cytotoxicity of hepatitis B virus peptides-induced CD8+ T cells in patients with acute hepatitis B
Interleukin-37 (IL-37) is a newly identified anti-inflammatory cytokine, owning immunosuppressive activity in infectious diseases. The aim of this study was to investigate the regulatory function of IL-37 on CD8+ T cells during hepatitis B virus (HBV) infection. Eighteen acute hepatitis B (AHB) pat...
Main Authors: | Qian Liu, Qiang Zhou, Mingrui Wang, Bo Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2023-05-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/8260 |
Similar Items
-
Interleukin-37 is involved in the immunopathogenesis of infectious mononucleosis
by: Mingsheng Zhao, et al.
Published: (2023-07-01) -
Interleukin‐37 promotes DMBA/TPA skin cancer through SIGIRR‐mediated inhibition of glycolysis in CD103+DC cells
by: Fan‐lian Zeng, et al.
Published: (2023-04-01) -
Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality
by: Shokichi Takahama, et al.
Published: (2023-10-01) -
Interleukin-35 Suppresses Interleukin-9-Secreting CD4+ T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma
by: Qian Zhang, et al.
Published: (2021-06-01) -
Interleukin-6 and Interleukin-10 Levels in Patients with Chronic Hepatitis B Virus Infection
by: Fatih YILDIZ, et al.
Published: (2007-03-01)